As of the latest SEC filings, Xilio Therapeutics, Inc. (XLO) is held by 8 institutional funds. The largest fund shareholder is VANGUARD EXTENDED MARKET INDEX FUND (VEMPX), holding an estimated $495,433.10 in market value, representing a significant portion of its portfolio.
Funds holding Xilio Therapeutics, Inc. (XLO)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- XLO
- CIK:
- 0001840233
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $495,433.10 | 58,910 | Mar 31, 2026 | May 28, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $434,754.95 | 51,695 | Mar 31, 2026 | May 28, 2026 |
|
VITNX
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND
|
MF | Vanguard | 0.00% | $109,792.55 | 13,055 | Mar 31, 2026 | May 28, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.00% | $74,963.66 | 141,896 | Feb 28, 2026 | Apr 24, 2026 |
|
FSKAX
Fidelity Total Market Index Fund
|
MF | Fidelity | 0.00% | $33,392.26 | 63,207 | Feb 28, 2026 | Apr 24, 2026 |
|
FCFMX
Fidelity Series Total Market Index Fund
|
MF | Fidelity | 0.00% | $26,195.23 | 49,584 | Feb 28, 2026 | Apr 24, 2026 |
|
FNCMX
Fidelity Nasdaq Composite Index Fund
|
MF | Fidelity | 0.00% | $7,563.14 | 14,316 | Feb 28, 2026 | Apr 24, 2026 |
|
GUG
Guggenheim Active Allocation Fund
|
CEF | Guggenheim | 0.00% | $22.72 | 43 | Feb 27, 2026 | Apr 29, 2026 |
Advertisement (320x50)